AIV Logo AIV Assistant

Loading...

 Logo Beximco Pharmaceuticals Limited - R2WA.F Open Beximco Pharmaceuticals Limited in new tab

0.40 EUR
P/E
4.00
EPS
0.10
Yield
7.87%
P/B
0.00
ROE
12.45
Beta
0.39

0.4000 EUR

0.400 EUR

Daily: +0.00%
Key Metrics

P/E: 4.00

EPS: 0.10

Book Value: 111.35

Price to Book: 0.00

Debt/Equity: 11.55

Growth

Revenue Growth: 0.13%

Earnings Growth: 0.28%

Dividend

Dividend Yield: 7.87%

Annual dividends: 0.03 EUR

Ex-Div. Date: Nov. 22, 2024

Payout: 27.85%

5y avg Yield: 5.28%

DCF Valuation

Tweak assumptions to recompute fair value for Beximco Pharmaceuticals Limited (R2WA.F)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About Beximco Pharmaceuticals Limited - (R2WA.F)

Country: Bangladesh

Sector: Health Care

Website: http://www.beximcopharma.com

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Exchange Ticker
FRA (Germany) BO9.F
SAO (Brazil) BOXP34.SA
MEX (Mexico) BXP.MX
FRA (Germany) R2WA.F
LSE (United Kingdom) BXP.L
STU (Germany) R2WA.SG
Dividend Yield

7.87% (5y avg: 5.28%)

Annual Dividends

0.03 EUR

Next ex. div date

Nov. 22, 2024

Payout Ratio

27.85%

Historical Dividends
Year Total Dividends
2025 0.04 EUR
2024 0.03 EUR
2023 0.03 EUR
2022 0.03 EUR
2021 0.04 EUR
2020 0.02 EUR
2019 0.02 EUR
2018 0.03 EUR
2017 0.01 EUR
2016 0.02 EUR
2015 0.01 EUR
2014 0.01 EUR
2009 0.00 EUR
2008 0.00 EUR

Yearly aggregated dividends

Dividends

Beximco Pharmaceuticals Limited
Nov 22, 2024 Paid
Dividend
0.0335 EUR

Historical Split Corporate Actions

Split Date Split Ratio to 1
June 27, 2008 10.000000
May 6, 2011 1.200000
May 18, 2012 1.210000
May 14, 2014 1.050000
May 19, 2015 1.050000
May 10, 2016 1.050000
Nov. 23, 2020 1.100000
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion